cas 1462289-96-8|| where to buy 3-cyclopropyl-4-methyl-2-oxo-pyrrolidine-3-carbonitrile

Nombre del producto:3-cyclopropyl-4-methyl-2-oxo-pyrrolidine-3-carbonitrile

IUPAC Name:3-cyclopropyl-4-methyl-2-oxopyrrolidine-3-carbonitrile

Unidad de embalaje	Stock disponible	Precio($)
CM1017797-1g	in stock	Ȑŵǜ
CM1017797-5g	1-2 Weeks	ƛƥũǶ
CM1017797-10g	1-2 Weeks	ƛũǜȡ
CM1017797-25g	1-2 Weeks	ȐŵȺȺ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1462289-96-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1462289-96-8; Fórmula molecular:C9H12N2O; Punto de fusión:-; Código de sonrisas:CC1CNC(=O)C1(C#N)C1CC1; Densidad:

: Número de catálogo:CM1017797; Peso molecular:164.21; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.